The stock price of Dolby Laboratories Inc (NYSE: DLB) has surged by 15.61 when compared to previous closing price of 70.91, but the company has seen a 11.49% gain in its stock price over the last five trading sessions. fool.com reported 2024-11-20 that Why Dolby Stock Just Popped 10%
Is It Worth Investing in Dolby Laboratories Inc (NYSE: DLB) Right Now?
Dolby Laboratories Inc (NYSE: DLB) has a price-to-earnings ratio that is above its average at 30.36x. The stock has a 36-month beta value of 0.96. Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 3 as “overweight,” 2 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for DLB is 58.68M, and at present, short sellers hold a 1.51% of that float. On November 21, 2024, the average trading volume of DLB was 387.46K shares.
DLB’s Market Performance
DLB’s stock has seen a 11.49% increase for the week, with a 11.87% rise in the past month and a 14.02% gain in the past quarter. The volatility ratio for the week is 3.91%, and the volatility levels for the past 30 days are at 2.11% for Dolby Laboratories Inc The simple moving average for the past 20 days is 10.90% for DLB’s stock, with a 5.67% simple moving average for the past 200 days.
Analysts’ Opinion of DLB
Many brokerage firms have already submitted their reports for DLB stocks, with Barrington Research repeating the rating for DLB by listing it as a “Outperform.” The predicted price for DLB in the upcoming period, according to Barrington Research is $100 based on the research report published on June 03, 2024 of the current year 2024.
Rosenblatt gave a rating of “Buy” to DLB, setting the target price at $90 in the report published on May 24th of the previous year.
DLB Trading at 10.87% from the 50-Day Moving Average
After a stumble in the market that brought DLB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -8.97% of loss for the given period.
Volatility was left at 2.11%, however, over the last 30 days, the volatility rate increased by 3.91%, as shares surge +12.78% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +17.87% upper at present.
During the last 5 trading sessions, DLB rose by +11.49%, which changed the moving average for the period of 200-days by +3.25% in comparison to the 20-day moving average, which settled at $73.92. In addition, Dolby Laboratories Inc saw -4.87% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at DLB starting from YEAMAN KEVIN J, who sale 28,512 shares at the price of $74.12 back on Oct 15 ’24. After this action, YEAMAN KEVIN J now owns 83,721 shares of Dolby Laboratories Inc, valued at $2,113,383 using the latest closing price.
YEAMAN FAMILY TRUST U/A DTD 05, the Officer of Dolby Laboratories Inc, proposed sale 28,512 shares at $74.12 during a trade that took place back on Oct 15 ’24, which means that YEAMAN FAMILY TRUST U/A DTD 05 is holding shares at $2,113,381 based on the most recent closing price.
Stock Fundamentals for DLB
Current profitability levels for the company are sitting at:
- 0.2 for the present operating margin
- 0.89 for the gross margin
The net margin for Dolby Laboratories Inc stands at 0.21. The total capital return value is set at 0.1. Equity return is now at value 10.84, with 8.55 for asset returns.
Based on Dolby Laboratories Inc (DLB), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at 26.74.
Currently, EBITDA for the company is 258.33 million with net debt to EBITDA at -1.55. When we switch over and look at the enterprise to sales, we see a ratio of 5.72. The receivables turnover for the company is 2.48for trailing twelve months and the total asset turnover is 0.41. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.86.
Conclusion
To sum up, Dolby Laboratories Inc (DLB) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
